The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Management of Febrile Neutropenia in Cancer

Time-sensitive risk-stratified evaluation and empirical antibiotic strategy after chemotherapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Management of Febrile Neutropenia in Cancer?

Febrile neutropenia is defined as a single oral temperature of thirty-eight point three degrees Celsius or sustained fever of thirty-eight degrees with an absolute neutrophil count below five hundred cells per microliter. The risk of bacteremia and rapid clinical deterioration mandates evaluation as a medical emergency rather than ambulatory follow-up.

Risk stratification with the MASCC or CISNE score separates low-risk patients eligible for oral antibiotics and outpatient management from high-risk patients who require admission for intravenous broad-spectrum therapy. Source evaluation includes a complete examination, blood cultures from each lumen of central catheters, urinalysis, and chest imaging when respiratory symptoms exist.

Empirical therapy uses an antipseudomonal beta-lactam such as piperacillin-tazobactam or cefepime adjusted by allergy, prior colonization, and local antibiograms. Adjunctive vancomycin is added for catheter-related infection, severe sepsis, or skin infection, and antifungal coverage is considered for persistent fever beyond seventy-two hours. Granulocyte colony-stimulating factor is used in selected high-risk regimens.

Symptoms

Sudden fever within ten to fourteen days of chemotherapy
Chills and rigors with neutropenia
Hypotension and tachycardia in severe sepsis
Mucositis or perirectal pain as portal of entry
Catheter site erythema or tenderness

Risk Factors

High-intensity cytotoxic chemotherapy
Prolonged severe neutropenia over seven days
Acute leukemia or stem cell transplantation
Indwelling central venous catheter
Mucositis or skin breakdown

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When fever appears in a neutropenic patient
  • When chills or rigors develop
  • When new hypotension or tachycardia is present
  • When catheter site changes
  • When fever persists despite empirical therapy

Treatment Methods

01
Risk stratification with MASCC or CISNE score
02
Blood cultures and source evaluation within sixty minutes
03
Empirical piperacillin-tazobactam or cefepime
04
Adjunctive vancomycin in selected indications
05
Antifungal therapy for persistent fever
06
Granulocyte colony-stimulating factor in selected regimens
07
Transition to oral therapy for low-risk patients

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.